Transcend Vivoscope Unveils Advanced Two-Photon Imaging Tech
Revolutionizing Biomedical Imaging with SUPERNOVA-600
Transcend Vivoscope has made a significant advancement in the field of biomedical imaging by introducing the SUPERNOVA-600, a state-of-the-art miniature two-photon microscopy (mTPM) system. This groundbreaking technology was announced today, signaling new opportunities for neuroscience research and innovation.
Innovative Features of SUPERNOVA-600
The SUPERNOVA-600 incorporates the patented TLens® tunable optics, which allows for real-time, optimal imaging of neuronal and cellular activities within the brain. This capability enhances the research landscape significantly, particularly in areas such as cognition, drug development, and neurological diseases like Alzheimer’s, Parkinson’s, and epilepsy.
Advanced Imaging Capabilities
Dr. Wu Runlong, the Director of R&D at Transcend Vivoscope, expressed excitement about the capabilities of the SUPERNOVA-600. He noted that it offers diverse combination configurations, enabling researchers to synchronize microscopic neuronal activity with the brain’s overall function effectively. This innovative system is a comprehensive solution for imaging freely moving animals, delivering high-quality, stable data output.
Rapid and Precise Focus
One of the standout features of this system is the low-power, fast, autofocus capabilities of the TLens®. These allow for rapid adjustments in focus, ensuring the best possible imaging quality. Researchers can now achieve a panoramic analysis of connectomes, furthering the understanding of brain function.
Collaboration and Future Prospects
The introduction of the SUPERNOVA-600 follows the successful launch of the SUPERNOVA-100 during Neuroscience 2023 and demonstrates Transcend Vivoscope’s commitment to innovation. The company is set to showcase the entire SUPERNOVA family at the upcoming Neuroscience 2024 conference.
Growing Interest in TLens® Technology
Dr. Oyvind Isaksen, CEO of poLight ASA, acknowledged the rising interest in TLens® technology following its use at the Kavli Institute. This technology not only won a Nobel Prize but has also captured the attention of numerous research groups globally, enhancing the landscape of mTPM systems.
A Forward-Thinking Approach
Transcend Vivoscope, founded in 2016 by a team of scientists from Peking University, has emerged as a pioneer in the application of miniature two-photon microscopy for neuroscience. The company aims to empower researchers by providing advanced imaging solutions.
About poLight ASA and Transcend Vivoscope
poLight ASA offers cutting-edge tunable optics technology, especially known for the TLens®, which mimics the human eye in devices ranging from smartphones to medical equipment. This technology enhances system performance, leads to unique user experiences, and reduces power consumption.
On the other hand, Transcend Vivoscope has garnered acclaim for its innovative brain imaging solutions, having achieved notable milestones such as obtaining clear images of brain cells in freely moving mice. Recognized as the 'Method of the Year 2018' by Nature Methods, their technologies have paved the way for new research possibilities.
Frequently Asked Questions
What is the SUPERNOVA-600?
The SUPERNOVA-600 is a miniature two-photon microscopy system developed by Transcend Vivoscope, designed to provide real-time imaging of neuronal and cellular activities.
How does the TLens® improve imaging?
The TLens® allows for rapid autofocus and optimal imaging quality, giving researchers greater flexibility and precision in their studies.
What are its applications?
This technology is particularly useful in neuroscience research, aiding studies on cognition, drug development, and diseases like Alzheimer’s and Parkinson’s.
Where will the SUPERNOVA-600 be displayed?
Transcend Vivoscope will showcase the SUPERNOVA-600 at booth #357 during the Neuroscience 2024 conference.
Who founded Transcend Vivoscope?
Transcend Vivoscope was founded in 2016 by a multidisciplinary team of scientists led by Prof. Cheng Heping from Peking University.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.